These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14109976)

  • 21. Studies on lymphocytes. XII. The role of immunologically committed lymphocytes in rejecting skin allografts.
    Chanana AD; Cronkite EP; Joel DD; Schiffer LM; Schnappauf H
    Transplantation; 1969 Jun; 7(6):459-67. PubMed ID: 4893035
    [No Abstract]   [Full Text] [Related]  

  • 22. [TRANSPLANTATION IMMUNITY. ON THE MECHANISM OF ANTIGENS IN HOMOGRAFTS].
    FUJII G
    Sogo Igaku; 1964 Mar; 21():215-20. PubMed ID: 14137779
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].
    Lawson RK; Kirchheim D
    Urologe; 1967; 6(6):359-67. PubMed ID: 4873352
    [No Abstract]   [Full Text] [Related]  

  • 24. Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula.
    Murray JE; Wilson RE; Tilney NL; Merrill JP; Cooper WC; Birtch AG; Carpenter CB; Hager EB; Dammin GJ; Harrison JH
    Ann Surg; 1968 Sep; 168(3):416-35. PubMed ID: 4175449
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative studies of lymphocyte decreasing measures].
    Pichlmaier H; Junginger T
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):293-9. PubMed ID: 4873614
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression with lymph depletion in man.
    Irvin GL; Carbone PP
    Surg Gynecol Obstet; 1967 Jun; 124(6):1283-7. PubMed ID: 6024206
    [No Abstract]   [Full Text] [Related]  

  • 27. Alymphocytosis, agammaglobulinaemia, homografts, and delayed hypersen sitivity: study of a case.
    ROSEN FS; GITLIN D; JANEWAY CA
    Lancet; 1962 Aug; 2(7252):380-1. PubMed ID: 14493891
    [No Abstract]   [Full Text] [Related]  

  • 28. The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation.
    Tilney NL; Murray JE
    Transplantation; 1967 Jul; 5(4):Suppl:1204-8. PubMed ID: 4860611
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of the mixed lymphocyte reaction to detect antilymphocytic serum activity.
    Schwarz MR
    J Reticuloendothel Soc; 1970 Jan; 7(1):146-57. PubMed ID: 4392303
    [No Abstract]   [Full Text] [Related]  

  • 30. EFFECTS OF RABBIT ANTI-RAT-LYMPHOCYTE PLASMA ON IMMUNE RESPONSE OF RATS THYMECTOMISED IN ADULT LIFE.
    JEEJEEBHOY HF
    Lancet; 1965 Jul; 2(7403):106-7. PubMed ID: 14330031
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of route of administration of antilymphocytic globulin on skin allograft survival in rats.
    Dalton RG; Touraine JL; Anderson NF; Woodruff MF
    Nature; 1970 Mar; 225(5238):1140-1. PubMed ID: 4907291
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats.
    Anderson NF; James K; Woodruff MF
    Lancet; 1967 May; 1(7500):1126-8. PubMed ID: 4164788
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes.
    Traeger J; Fries D; Revillard JP; Durix A; Carraz M; Plan M
    Fed Proc; 1970; 29(1):108-10. PubMed ID: 4904617
    [No Abstract]   [Full Text] [Related]  

  • 34. IMMUNOSUPPRESSIVE DRUG THERAPY IN CANINE RENAL AND SKIN HOMOGRAFTS.
    ALEXANDRE GP; MURRAY JE; DAMMIN GJ; NOLAN B
    Transplantation; 1963 Oct; 1():432-61. PubMed ID: 14071252
    [No Abstract]   [Full Text] [Related]  

  • 35. HOMOGRAFT SENSITIVITY REACTIONS IN IRRADIATED HAMSTERS.
    RAMSEIER H; STREILEIN JW
    Lancet; 1965 Mar; 1(7386):622-4. PubMed ID: 14255213
    [No Abstract]   [Full Text] [Related]  

  • 36. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiserum to lymphocytes: interactions with chemical immunosuppressants.
    Immons RL; Ozerkis AJ; Hoehn RJ
    Science; 1968 Jun; 160(3832):1127-30. PubMed ID: 4869606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of the indirect fluorescent antibody technique in assessing the activity of antilymphocytic sera and antilymphocytic globulins.
    Thomas D; Mosedale B; Zola H
    Clin Exp Immunol; 1971 Jun; 8(6):987-91. PubMed ID: 4997074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SURVIVAL OF SKIN HOMOGRAFTS AFTER TREATMENT WITH HOMOGENATES OF ORGANS AND HOMOLOGOUS AND HETEROLOGOUS TISSUES].
    TENDELLA E; SEGATO G; MANTOVANI-ORSETTI G; ROSA G
    Acta Chir Ital; 1964; 20():641-8. PubMed ID: 14256665
    [No Abstract]   [Full Text] [Related]  

  • 40. Thoracic duct lymphocyte depletion for renal allografts.
    JAMA; 1970 Mar; 211(11):1847. PubMed ID: 4905891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.